Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-07-05 2021-07-05
Drug Identification Number 02340208 02340208
Brand name SANDOZ TAMSULOSIN CR SANDOZ TAMSULOSIN CR
Common or Proper name SANDOZ TAMSULOSIN CR SANDOZ TAMSULOSIN CR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TAMSULOSIN HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500PRT BO V1 CA 500PRT BO V1 CA
ATC code G04CA G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-25 2021-06-25
Estimated end date 2021-07-02 2021-07-02
Actual end date 2021-07-02 2021-07-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments